These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 12535736)

  • 1. Enhanced bridging function and augmented monocyte adhesion by lipoprotein lipase N9: insights into increased risk of coronary artery disease in N9 carriers.
    Fisher RM; Benhizia F; Schreiber R; Makoveichuk E; Putt W; Al-Haideri M; Deckelbaum RJ; Olivecrona G; Humphries SE; Talmud PJ
    Atherosclerosis; 2003 Feb; 166(2):243-51. PubMed ID: 12535736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The common mutations in the lipoprotein lipase gene in Italy: effects on plasma lipids and angiographically assessed coronary atherosclerosis.
    Arca M; Campagna F; Montali A; Barillà F; Mangieri E; Tanzilli G; Seccareccia F; Campa PP; Ricci G; Pannitteri G
    Clin Genet; 2000 Nov; 58(5):369-74. PubMed ID: 11140837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substitution of asparagine for aspartic acid at residue 9 (D9N) of lipoprotein lipase markedly augments risk of ischaemic heart disease in male smokers.
    Talmud PJ; Bujac SR; Hall S; Miller GJ; Humphries SE
    Atherosclerosis; 2000 Mar; 149(1):75-81. PubMed ID: 10704617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic variant showing a positive interaction with beta-blocking agents with a beneficial influence on lipoprotein lipase activity, HDL cholesterol, and triglyceride levels in coronary artery disease patients. The Ser447-stop substitution in the lipoprotein lipase gene. REGRESS Study Group.
    Groenemeijer BE; Hallman MD; Reymer PW; Gagné E; Kuivenhoven JA; Bruin T; Jansen H; Lie KI; Bruschke AV; Boerwinkle E; Hayden MR; Kastelein JJ
    Circulation; 1997 Jun; 95(12):2628-35. PubMed ID: 9193431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipoprotein lipase can function as a monocyte adhesion protein.
    Obunike JC; Paka S; Pillarisetti S; Goldberg IJ
    Arterioscler Thromb Vasc Biol; 1997 Jul; 17(7):1414-20. PubMed ID: 9261275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activity and concentration of lipoprotein lipase in post-heparin plasma and the extent of coronary artery disease.
    Dugi KA; Schmidt N; Brandauer K; Ramacher D; Fiehn W; Kreuzer J
    Atherosclerosis; 2002 Jul; 163(1):127-34. PubMed ID: 12048130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between the LPL-D9N mutation in the lipoprotein lipase gene and plasma lipid traits in myocardial infarction survivors from the ECTIM Study.
    Mailly F; Fisher RM; Nicaud V; Luong LA; Evans AE; Marques-Vidal P; Luc G; Arveiler D; Bard JM; Poirier O; Talmud PJ; Humphries SE
    Atherosclerosis; 1996 Apr; 122(1):21-8. PubMed ID: 8724108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The LPL S447X cSNP is associated with decreased blood pressure and plasma triglycerides, and reduced risk of coronary artery disease.
    Clee SM; Loubser O; Collins J; Kastelein JJ; Hayden MR
    Clin Genet; 2001 Oct; 60(4):293-300. PubMed ID: 11683775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipoprotein lipase gene polymorphisms in Croatian patients with coronary artery disease.
    Ferencak G; Pasalić D; Grsković B; Cheng S; Fijal B; Sesto M; Skodlar J; Rukavina AS
    Clin Chem Lab Med; 2003 Apr; 41(4):541-6. PubMed ID: 12747600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of lipoprotein lipase serine 447 stop polymorphism on tracking of triglycerides and HDL cholesterol from childhood to adulthood and familial risk of coronary artery disease: the Bogalusa heart study.
    Chen W; Srinivasan SR; Elkasabany A; Ellsworth DL; Boerwinkle E; Berenson GS
    Atherosclerosis; 2001 Dec; 159(2):367-73. PubMed ID: 11730816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphisms in the gene encoding lipoprotein lipase in men with low HDL-C and coronary heart disease: the Veterans Affairs HDL Intervention Trial.
    Brousseau ME; Goldkamp AL; Collins D; Demissie S; Connolly AC; Cupples LA; Ordovas JM; Bloomfield HE; Robins SJ; Schaefer EJ
    J Lipid Res; 2004 Oct; 45(10):1885-91. PubMed ID: 15292370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Very-low-density lipoprotein-induced triglyceride accumulation in human mesangial cells is mainly mediated by lipoprotein lipase.
    Li J; Li H; Wen YB; Li XW
    Nephron Physiol; 2008; 110(1):p1-10. PubMed ID: 18698144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complete rescue of lipoprotein lipase-deficient mice by somatic gene transfer of the naturally occurring LPLS447X beneficial mutation.
    Ross CJ; Liu G; Kuivenhoven JA; Twisk J; Rip J; van Dop W; Excoffon KJ; Lewis SM; Kastelein JJ; Hayden MR
    Arterioscler Thromb Vasc Biol; 2005 Oct; 25(10):2143-50. PubMed ID: 16002740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apolipoprotein E and lipoprotein lipase gene polymorphisms interaction on the atherogenic combined expression of hypertriglyceridemia and hyperapobetalipoproteinemia phenotypes.
    Perron P; Brisson D; Santuré M; Blackburn P; Bergeron J; Vohl MC; Després JP; Gaudet D
    J Endocrinol Invest; 2007; 30(7):551-7. PubMed ID: 17848837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced conversion of triglyceride-rich lipoproteins and increased low-density lipoprotein removal in LPLS447X carriers.
    Nierman MC; Prinsen BH; Rip J; Veldman RJ; Kuivenhoven JA; Kastelein JJ; de Sain-van der Velden MG; Stroes ES
    Arterioscler Thromb Vasc Biol; 2005 Nov; 25(11):2410-5. PubMed ID: 16195478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenovirus-mediated gene transfer of human lipoprotein lipase ameliorates the hyperlipidemias associated with apolipoprotein E and LDL receptor deficiencies in mice.
    Zsigmond E; Kobayashi K; Tzung KW; Li L; Fuke Y; Chan L
    Hum Gene Ther; 1997 Nov; 8(16):1921-33. PubMed ID: 9382958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipoprotein lipase variants D9N and N291S are associated with increased plasma triglyceride and lower high-density lipoprotein cholesterol concentrations: studies in the fasting and postprandial states: the European Atherosclerosis Research Studies.
    Gerdes C; Fisher RM; Nicaud V; Boer J; Humphries SE; Talmud PJ; Faergeman O
    Circulation; 1997 Aug; 96(3):733-40. PubMed ID: 9264476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional significance of lipoprotein lipase HindIII polymorphism associated with the risk of coronary artery disease.
    Chen Q; Razzaghi H; Demirci FY; Kamboh MI
    Atherosclerosis; 2008 Sep; 200(1):102-8. PubMed ID: 18242618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Rare and Common Variation in the Lipoprotein Lipase Gene With Coronary Artery Disease.
    Khera AV; Won HH; Peloso GM; O'Dushlaine C; Liu D; Stitziel NO; Natarajan P; Nomura A; Emdin CA; Gupta N; Borecki IB; Asselta R; Duga S; Merlini PA; Correa A; Kessler T; Wilson JG; Bown MJ; Hall AS; Braund PS; Carey DJ; Murray MF; Kirchner HL; Leader JB; Lavage DR; Manus JN; Hartzel DN; Samani NJ; Schunkert H; Marrugat J; Elosua R; McPherson R; Farrall M; Watkins H; Lander ES; Rader DJ; Danesh J; Ardissino D; Gabriel S; Willer C; Abecasis GR; Saleheen D; Dewey FE; Kathiresan S;
    JAMA; 2017 Mar; 317(9):937-946. PubMed ID: 28267856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipoprotein lipase (LPL) gene variation and progression of carotid artery plaque.
    Spence JD; Ban MR; Hegele RA
    Stroke; 2003 May; 34(5):1176-80. PubMed ID: 12690214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.